搜索筛选:
搜索耗时0.0831秒,为你在为你在102,285,761篇论文里面共找到 13 篇相符的论文内容
发布年度:
Asymptotic Behavior of Solutions of a Free Boundary Problem Modeling Multi-layer Tumor Growth in Pre
[期刊论文] 作者：Xiu Mei HOU,
来源：黑龙江科技学院学报 年份：2011
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7...
[期刊论文] 作者：DU Mei,HOU Yijun,GUO Yunxia,WA,
来源：中国海洋大学学报:英文版 年份：2020
Coastal inundation results in many human casualties and significant economic losses.In this study,an inundation model with an unstructured mesh was developed us...
Numerical Simulation and Risk Analysis of Coastal Inundation in Land Reclamation Areas: A Case Study
[期刊论文] 作者：DU Mei,HOU Yijun,GUO Yunxia,WANG Kai,
来源：中国海洋大学学报（自然科学英文版） 年份：2020
Coastal inundation results in many human casualties and significant economic losses. In this study, an inundation model with an unstructured mesh was developed...
[会议论文] 作者：Ping Chen,Jiang Zhu,Ding-yi Liu,Hui-yan Li,Nie Xu,Mei Hou,
来源：四川省医学会第三次肿瘤学学术会议 年份：2016
Background: The expression of Survivin,an inhibitor of apoptosis can be seen in most tumors and is correlated with the angiogenic factor vascular endothelial growth factor(VEGF).But little is known ab...
[会议论文] 作者：liang ping,zhang yuanming,xu jun,ma mei,hou xiuli,zhang yuan,
来源：中华医学会第十八次全国心血管大会暨2016长安国际心血管病论坛 年份：2016
...
Overall survival (OS) with afatinib (A) vs gemcitabine/cisplatin (GC) in treatment-naive Chinese pat
[会议论文] 作者：Yi-Long Wu,Caicun Zhou,Cheng-Ping Hu,Jifeng Feng,Shun Lu,Yunchao Huang,Wei Li,Mei Hou,Jianhua Shi,Dan,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
Overall survival (OS) with afatinib (A) vs gemcitabine/cisplatin (GC) in treatment-naive Chinese pat
[会议论文] 作者：Yi-Long Wu,Caicun Zhou,Cheng-Ping Hu,Jifeng Feng,Shun Lu,Yunchao Huang,Wei Li,Mei Hou,Jianhua Shi,Dan,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective:A, an oral, irreversible ErbB family blocker, was compared with GC in 364 Asian pts with EGFR mut positive NSCLC, including 327 pts from China.PFS was significantly prolonged with A vs GC in...
[会议论文] 作者：Zhao,Xiaojuan Zhou,Yong Xu,Youling Gong,Meijuan Huang,Feng Peng,Lin Zhou,Jiang Zhu,Jin Wang,Li Ren,Mei Hou,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Central nervous system (CNS) progression is frequently detected in patients with favorable initial responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs), but...
LUX-Lung 6: A randomized, open-label, Phase Ⅲ study of afatinib vs.gemcitabine/cisplatin as first-li
[会议论文] 作者：Yi-Long Wu,Sarayut L Geater,Cheng-Ping Hu,Jifeng Feng,Shun Lu,Yunchao Huang,Wei Li,Jian Hua Shi,Mei Hou,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
...
LUX-Lung 6: A randomized, open-label, Phase Ⅲ study of afatinib vs.gemcitabine/cisplatin as first-li
[会议论文] 作者：Yi-Long Wu,Sarayut L Geater,Cheng-Ping Hu,Jifeng Feng,Shun Lu,Yunchao Huang,Wei Li,Jian Hua Shi,Mei Hou,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
Background: Afatinib is an oral, irreversible, ErbB Family Blocker, blocking signaling from EGFR (ErbB1), HER2 (ErbB2) and ErbB4.Afatinib was superior to first-line pemetrexed/cisplatin in terms of pr...
Interactome analysis identifies a new paralogue of XRCC4 in nonhomologous end joining DNA repair pat
[会议论文] 作者：Mingrui Yang,Wei Huo,Feng Feng,Leizhen Wei,Wenxia Jiang,Shaokai Ning,Zhenxin Yan,Wen Li,Qingsong Wang,Mei Hou,
来源：中国细胞生物学学会2015年全国学术大会 年份：2015
Non-homologous end joining (NHEJ) is a major pathway for the repair of DNA double-strand breaks (DSBs),which can display different types of broken ends....
[期刊论文] 作者：Yao,Shiying Yu,Feng Yu,Jun Ma,Jiejun Wang,Jifeng Feng,Guoping Sun,Jiliang Yin,Yuan Chen,Li Zhang,Mei Hou,
来源：Oncology and Translational Medicine 年份：2015
Overview Drug-induced liver injury(DILI)due to acetaminophen overdose and idiosyncratic drug reactions usually occurs 5–90 days after exposure to the causative...
Interactome analysis identifies a new paralogue of XRCC4 in nonhomologous end joining DNA repair pat
[会议论文] 作者：Gao,Zhenxin Yan,Rong Guo,Mengtan Xing,Qingsong Wang,Jianguo Ji,Shaokai Ning,Chunxia Dong,Wei Huo,Mei Hou,
来源：中国细胞生物学学会2015年全国学术大会 年份：2015
...
相关搜索：
